Overview

Global Risk-based Monitoring Software Market is predicted to value over USD 600 million by 2027 end with a CAGR of over 13% during the forecast period 2020 to 2027.

Increasing efficiency and cost of risk-based monitoring solutions, growing investments by governments for bolstering clinical trials owing to its rising demand are some of the key factors driving the risk-based monitoring software market growth.

Risk-based Monitoring Software Market

Risk-based Monitoring Software Market Segmentation:

By Type
• Enterprise
• Site

By Component
• Software
• Services

By Delivery Mode
• Licensed Enterprise
• Cloud-Based
• Web-Based

By End User
• CROs
• Medical Device Companies
• Biopharmaceutical and Pharmaceutical Companies
• Others

By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

The market is categorised into type, component, delivery mode, end user and region. The type segment is diversified into enterprise and site. The component segment is divided into software and services. The software segment is anticipated to hold the largest risk-based monitoring software market share, and this can be credited to the increasing demand for clinical trials and rising research and development expense in the life sciences sector. The delivery mode segment is divided into licensed enterprise, cloud-based and web-based. The web-based segment is anticipated to lead the market owing to benefits provided such as improvements in productivity, cost-efficiency and time efficiency. The end user segment is fragmented into CROs, medical device companies, biopharmaceutical and pharmaceutical companies and others. The pharmaceutical and biopharmaceutical companies are predicted to dominate the market due to the availability of resources with these companies which lets them expand businesses in developed as well as developing economies.

Regional Analysis:
The North America region is expected to lead the market during the forecast period owing to increased funding from government bodies for clinical trials, non-stringent regulations and a presence of key market players. The Asia Pacific region is predicted to grow at a substantial rate owing to rising patient population, key market players expanding their businesses in the region, low operation costs.

Competitive Landscape:
Some of the key players are Oracle, Medidata Solutions, Parexel, Bioclinica, Bio-Optronics, IBM Corporation, DATATRAK, Veeva Systems, DSG, MasterControl, ERT, Forte Research Systems, MedNet Solutions, ArisGlobal, Anju Software, MaxisIT, Techsol Corporation, OpenClinica, CRF Health, Covance.

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the global risk-based monitoring software market by type, by component, by delivery model, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com